Gayatri Premasekharan

Author

UCSF Helen Diller Family Comprehensive Cancer Center

Also Known As

Gayatri Premasekharan

Publications

621

Citations

H-Index

Concepts

All Affiliations

UCSF Helen Diller Family Comprehensive Cancer Center University of California, San Francisco Epic Sciences (United States)

About

Gayatri Premasekharan is an author at UCSF Helen Diller Family Comprehensive Cancer Center specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	178
2	Cell Biology	3	3	129
3	Immunology	2	2	116
4	Engineering	1	1	27
5	Pathology	1	1	13

Gayatri Premasekharan

Publications

532

Citations

H-Index

Page 1

	Year	Citations
Detection and characterization of invasive circulating tumor cells derived from men with metastatic castration-resistant prostate cancer Terence W. Friedlander, Vy Ngo, Huan Dong, International Journal of Cancer	2013	126
Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients Archana Anantharaman, Terence W. Friedlander, David Lu, BMC Cancer	2016	105
Circulating Tumor Cells as Potential Biomarkers in Bladder Cancer Ajjai Alva, Terence W. Friedlander, Melanie Clark, The Journal of Urology	2015	86
Targeting CD46 for both adenocarcinoma and neuroendocrine prostate cancer Su Yang, Yue Liu, Christopher R. Behrens, JCI Insight Cancer ImmunosurveillanceGenitourinary CancerNeuroendocrine Prostate CancerAnti-cd46 AntibodyImmunology	2018	83
Iron-mediated lipid peroxidation and lipid raft disruption in low-dose silica-induced macrophage cytokine production Gayatri Premasekharan, Kennedy Nguyen, Janette Contreras, Free Radical Biology and Medicine InflammationLipid PeroxidationImmunologyChronic InflammationLipid Raft Disruption	2011	33
An improved CTC isolation scheme for pairing with downstream genomics: Demonstrating clinical utility in metastatic prostate, lung and pancreatic cancer Gayatri Premasekharan, Elizabeth Gilbert, Ross A. Okimoto, Cancer Letters Radiation OncologyFunctional GenomicsEngineeringPancreatic CancerTumor Heterogeneity	2016	27
High-Dose Abiraterone Acetate in Men With Castration Resistant Prostate Cancer Terence W. Friedlander, Julie N. Graff, Kreshnik Zejnullahu, Clinical Genitourinary Cancer UrologyOncologyMedicineHigh-dose Abiraterone AcetateBenign Prostatic Hyperplasia	2017	22
Real-Time Transferrin-Based PET Detects MYC-Positive Prostate Cancer Rahul Aggarwal, Spencer C. Behr, Pamela L. Paris, Molecular Cancer Research	2017	19
Measurement of copy number variation in single cancer cells using rapid-emulsification digital droplet MDA Samuel Kim, Gayatri Premasekharan, Iain C. Clark, Microsystems & Nanoengineering	2017	18
Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients. Archana Anantharaman, Terence W. Friedlander, David Lu, Journal of Clinical Oncology ImmunoeditingPathologyTumor CellsImmunotherapeuticsPd-l1 Checkpoint Inhibitors	2016	13

Page 1